French health authorities reported the emergence of the Shamonda virus in a human for the first time. This case involved a severely immunocompromised patient who tragically passed away in Lyon. Investigations suggest the virus was contracted through an insect bite, likely from the Culicoides midge. Although the Shamonda virus has been prevalent in livestock, no general health risk has currently…
The French health authorities have reported the detection of the Shamonda virus in a human for the first time, with the patient dying in Lyon in early October. The individual, who was severely immunocompromised, had been receiving treatment for a serious illness. French authorities have stated that there is currently no identified health risk to the general population, as investigations into the case are ongoing.
The French agriculture ministry described this case as exceptional, as the virus had been considered non-transmissible to humans until now.
Brief written by urgent.news from Times of India's own syndicated text.
Machine-written — may contain errors; check the original before relying on it.
Karachi’s Jinnah International Airport has extended the deadline for enforcing mandatory vaccination checks for Umrah pilgrims and other passengers traveling … Read More The post Karachi Airport…
[Vanguard] The Association of Medical Laboratory Scientists of Nigeria (AMLSN), Kaduna State Branch, has advised political parties to campaign virtually to minimise physical contact amid the Ebola…
Agency declines to reveal in which state latest measles death occurred as it delays reporting other measles deaths The US Centers for Disease Control and Prevention (CDC) added a third measles death…
[Premium Times] Mr Pate described the response as a continuation of Nigeria's experience in managing public health emergencies, recalling how the country contained the Ebola outbreak in 2014.
[Premium Times] The Director-General of the Lagos State Sports Commission, Lekan Fatodu, said the initiatives demonstrated how sporting activities could be used to address social challenges beyond…
Where other European pharmas — notably Novartis, Novo and AstraZeneca — have suffered huge late-stage clinical failures this summer, Roche is feeling rather smug. CEO Thomas Schinecker said ...
